EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
2024 · Cancer Cell · 45 citations
https://doi.org/10.1016/j.ccell.2024.11.006
X
Xi Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
127
Citations
6
h-index
4
i10-index
Xi Chen is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & Chronic Obstructive Pulmonary Disease (COPD) Research. The author has an h-index of 6, co-authored 12 publications.
ORCID: 0000-0002-6875-7830Papers by this author
worksCLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
2023 · Journal for ImmunoTherapy of Cancer · 34 citations
https://doi.org/10.1136/jitc-2023-006704
Progesterone (P4) ameliorates cigarette smoke-induced chronic obstructive pulmonary disease (COPD)
2024 · Molecular Medicine · 14 citations
https://doi.org/10.1186/s10020-024-00883-y
Analysis of the acoustoelectric response of SAW gas sensors using a COM model
2024 · Microsystems & Nanoengineering · 9 citations
https://doi.org/10.1038/s41378-024-00673-w
Clinically friendly smart hydrogel boosts cuproptosis and PD-L1 upregulation to enhance anti-tumor immunotherapy
2025 · Materials Today Bio · 0 citations
https://doi.org/10.1016/j.mtbio.2025.102268
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat